Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_assertion type Assertion NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_head.
- NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_assertion description "[Ex vivo, synovial ECs from patients with either OA or RA displayed a higher CXCL12-binding capacity than human umbilical vein ECs (HUVECs), and in HUVECs the binding of CXCL12 was increased on exposure to tumor necrosis factor-alpha or lymphotoxin-alpha1beta2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_provenance.
- NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_assertion evidence source_evidence_literature NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_provenance.
- NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_assertion SIO_000772 16507142 NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_provenance.
- NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_assertion wasDerivedFrom befree-20140225 NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_provenance.
- NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_assertion wasGeneratedBy ECO_0000203 NP891631.RAQYc2JSW7A0U_OzNobGeOfcpPqvPopuGc0tN0phYqLJc130_provenance.